A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia
Condition: 2019-nCoV Pneumonia Interventions: Drug: ASC09F+Oseltamivir; Drug: Ritonavir+Oseltamivir; Drug: Oseltamivir Sponsor: Tongji Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2020 Category: Research Source Type: clinical trials